News

Check out market updates

Longmont pharma plant adds $6M in value over two years

LONGMONT — Novartis AG (NYSE: NVS) gene therapy subsidiary AveXis sold off its idle pharmaceutical plant last week for $36 […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *

X